AIS performance

Performance of the AIS stock (ANTARES PHARMA) versus S&P 500 Index(^SPX)

Loading the AIS performance compared to the performance of the S&P 500 Index ...

AIS Stock and Index Performance

Technical Analysis - ANTARES PHARMA (Stock Symbol: AIS)

AIS Stock's Performance
Enter Stock's Symbol   US  Canadian 

The performance tables below will allow you to compare the performance of the ANTARES PHARMA (AIS) stock and the S&P 500 Index(^SPX) (you may select other index from the list below). We provide performance comparison for the most recent trading session, for the past month (30 days) for 52 weeks (1-year) and YTD.

Several timeframes help evaluating whether current AIS stock's performance is in the range of the average yearly, monthly or YTD performance. The "Ratio (%)" is calculated as a ration between SPX index and AIS stock data. Since SPX index and AIS stock prices are in different range the "Ratio (%)" helps to compare SPX index and AIS stock performances. At the same time the "Ratio (%)" allows to see what percentage of index's volume (if AIS stock is listed in the SPX index) belongs to the AIS stock.

AIS ChartsAIS QuotesAIS AnalysisAIS Price
Calculators		AIS Volume
Calculators		AIS Volatility
Calculators
Compare and ANTARES PHARMA (AIS) stock.

Today's Performance Comparison:
S&P 500 Index(^SPX) vs ANTARES PHARMA (AIS)

 Delayed Quotes - U.S. Market close in 3 hours and 35 minutes.
S&P 500 Index(^SPX)ANTARES PHARMA (AIS)Ratio (%)
Last Trade1,329.13 Last Trade3.300.25
Trade Time (ET)06/14/2012 00:00Trade Time (ET)06/14/2012 00:00
Change14.30(1.09%) Change0.11(3.45%)0.77
Previous Close1,314.83 Previous Close3.190.24
Open1,314.88 Open3.180.24
High1,333.68 High3.300.25
Low1,314.14 Low3.170.24
VolumeSign Up K Volume561 K

1-Month Performance Comparison:
S&P 500 Index(^SPX) vs ANTARES PHARMA (AIS)

S&P 500 Index(^SPX)ANTARES PHARMA (AIS)Ratio (%)
1-month Change14.30(1.09%) 1-month Change0.11(3.45%)0.77
1-month High0.00 1-month High0.00
1-month Low0.00 1-month Low0.00
Average Daily VolumeSign Up K Average Daily Volume0 K
Average Daily Change0.00 % Average Daily Change0.00 %

YTD Performance Comparison:
S&P 500 Index(^SPX) vs ANTARES PHARMA (AIS)

S&P 500 Index(^SPX)ANTARES PHARMA (AIS)Ratio (%)
YTD Change14.30(1.09%) YTD Change0.11(3.45%)0.77
YTD High0.00 YTD High0.00
YTD Low0.00 YTD Low0.00
Average Daily VolumeSign Up K Average Daily Volume0 K
Average Daily Change0.00 % Average Daily Change0.00 %

52-week (1 year) Performance Comparison:
S&P 500 Index(^SPX) vs ANTARES PHARMA (AIS)

S&P 500 Index(^SPX)ANTARES PHARMA (AIS)Ratio (%)
52-week Change10.41(0.79%) 52-week Change0.37(12.63%)3.55
52-week High1,335.52 52-week High3.330.25
52-week Low1,266.74 52-week Low2.600.21
Average Daily VolumeSign Up K Average Daily Volume985 K
Average Daily Change0.89 % Average Daily Change2.18 %244.06

S&P 500 Index(^SPX) and ANTARES PHARMA (AIS) aligned chart.

ANTARES PHARMA (AIS) and S&P 500 Index(^SPX) Comparison Flash Graph

ANTARES PHARMA (AIS) vs S&P 500 Index(^SPX) performance.

ANTARES PHARMA (AIS) vs S&P 500 Index(^SPX) Performance Flash Graph
 
About S&P 500 Index(^SPX)

The S&P 500 ("Standard & Poor's 500 Stock Index") is widely regarded as the standard for measuring large-cap U.S. stock market performance. This is one of the most popular indexes representing the top 500 companies in leading industries (most of them listed on the New York Stock Exchange).		   About ANTARES PHARMA (AIS)

Antares Pharma, Inc., a pharmaceutical company, focuses on self-injection pharmaceutical products and technologies, and topical gel-based products. It offers injection devices, which include Zomajet 2 Vision, Zomajet Vision X, Twin-Jector EZ II, and Tjet for human growth hormone; Medi-Jector Vision for insulin; Vibex disposable pressure assisted auto injectors that enables a controlled pressure delivery of drugs into the body utilizing a spring power source; and disposable pen injectors, which are needle-based devices designed to deliver multiple injections from multi-dose drug cartridges. The company also provides Anturol, an oxybutynin ATD (advanced transdermal delivery)gel, which is in Phase III clinical trials for the treatment of overactive bladder; Elestrin, a transdermal estradiol gel for the treatment of moderate-to-severe vasomotor symptoms associated with menopause; LibiGel, a transdermal testosterone gel that is in Phase III clinical studies for the treatment of female sexual dysfunction; and Nestorone contraceptive formulation products, which has completed Phase II clinical trials. Antares Pharma, Inc. markets its products to pharmaceutical companies primarily in the United States and Europe. It has collaborative arrangements and license agreements with Teva Pharmaceutical Industries, Ltd.; Ferring Pharmaceuticals BV; JCR Pharmaceuticals Co., Ltd.; BioSante Pharmaceuticals, Inc.; Jazz Pharmaceuticals; and Population Council. The company was founded in 1979 and is based in Ewing, New Jersey.
 
Copyright © 1997-2013 MarketVolume.com: You may not copy, distribute, transmit, display, perform, reproduce, publish, license, sublicense, create derivative works from, transfer or sell any of the Information. More...
  Close this Window
Close

You are logged Out of the Members' Area

To have access to real-time quotes, charts, trading signals and fresh market outlook you have to be logged in:

Not a member yet?
Click here to become a full member of MarketVolume® and enjoy the benefits of a feature rich market timing system!

No, Thanks, I would like to check the website first.

Close this Window

Start using our Professional Charts and Make Money with our System!
Sign up for a Free Trial Now!

What else are you waiting for?

Try it for FREE >>>

Disclaimer | Privacy © 1997-2013 Highlight Investments Group. All Rights Reserved. / SV1